Adjuvant TACE inhibitor treatment improves the outcome of TLR2-/- mice with experimental pneumococcal meningitis

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Echchannaoui, Hakim ^a   Leib, Stephen L ^b   Neumann, Ulf ^c   Landmann, Regine M A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; TNF 484; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; UNCLASSIFIED DRUG; ADAM PROTEIN; ANTIINFECTIVE AGENT; CD14 ANTIGEN; HYDROXAMIC ACID; N(4) (2,2 DIMETHYL 1 METHYLCARBAMOYLPROPYL) N(1) HYDROXY 2 HYDROXYMETHYL 3 (4 METHOXYPHENYL)SUCCINAMIDE; N(4)-(2,2-DIMETHYL-1-METHYLCARBAMOYLPROPYL)-N(1)-HYDROXY-2-HYDROXYMETHYL-3-(4-METHOXYPHENYL)SUCCINAMIDE; TLR2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BRAIN; CEREBROSPINAL FLUID; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; LEUKOCYTE; MOUSE; NONHUMAN; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL; WILD TYPE; ADJUVANT CHEMOTHERAPY; ANIMAL; C57BL MOUSE; DRUG ANTAGONISM; ENZYMOLOGY; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALE; METABOLISM; MICROBIOLOGY; MOUSE MUTANT; STREPTOCOCCUS INFECTION;

ADAM PROTEINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD14; CEFTRIAXONE; CHEMOTHERAPY, ADJUVANT; FEMALE; HYDROXAMIC ACIDS; MALE; MENINGITIS, PNEUMOCOCCAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247529539     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-25     Document Type: Article

References (32)

1. Schuchat A Robinson K Wenger JD Harrison LH Farley M Reingold AL Lefkowitz L Perkins BA Bacterial meningitis in the United States in 1995. Active Surveillance Team N Engl J Med 1997 337 14 970-976 10.1056/ NEJM199710023371404 9395430
2. Scheld WM Koedel U Nathan B Pfister HW Pathophysiology of bacterial meningitis: Mechanism(s) of neuronal injury J Infect Dis 2002 186 Suppl 2 S225-33 10.1086/344939 12424702
3. Koedel U Scheld WM Pfister HW Pathogenesis and pathophysiology of pneumococcal meningitis Lancet Infect Dis 2002 2 12 721-736 10.1016/ S1473-3099(02)00450-4 12467688
4. Pomar V Martinez S Paredes R Domingo P Advances in adjuvant therapy against acute bacterial meningitis Curr Drug Targets Infect Disord 2004 4 4 303-309 10.2174/1568005043340579 15578971
5. Leib SL Heimgartner C Bifrare YD Loeffler JM Taauber MG Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats Pediatr Res 2003 54 3 353-357 10.1203/ 01.PDR.0000079185.67878.72 12788989
6. Echchannaoui H Frei K Schnell C Leib S Zimmerli W Landmann R Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis due to reduced bacterial clearing and enhanced inflammation J Infect Dis 2002 186 6 798-806 10.1086/342845 12198614
7. Leib SL Clements JM Lindberg RL Heimgartner C Loeffler JM Pfister LA Tauber MG Leppert D Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis Brain 2001 124 Pt 9 1734-1742 10.1093/brain/ 124.9.1734 11522576
8. Leib SL Leppert D Clements J Tauber MG Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis Infect Immun 2000 68 2 615-620 97183 10639424 10.1128/ IAI.68.2.615-620.2000
9. Meli DN Christen S Leib SL Tauber MG Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae Curr Opin Infect Dis 2002 15 3 253-257 12015459
10. Kottirsch G Koch G Feifel R Neumann U Beta-aryl-succinic acid hydroxamates as dual inhibitors of matrix metalloproteinases and tumor necrosis factor alpha converting enzyme J Med Chem 2002 45 11 2289-2293 10.1021/jm0110993 12014967
11. Letiembre M Echchannaoui H Bachmann P Ferracin F C. N Espinosa M Landmann R TLR2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes 2 Infect Immun 2005 73 12 8397-401
12. Brightbill HD Libraty DH Krutzik SR Yang RB Belisle JT Bleharski JR Maitland M Norgard MV Plevy SE Smale ST Brennan PJ Bloom BR Godowski PJ Modlin RL Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors Science 1999 285 5428 732-736 10.1126/ science.285.5428.732 10426995
13. Schwandner R Dziarski R Wesche H Rothe M Kirschning CJ Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2 J Biol Chem 1999 274 25 17406-17409 10.1074/jbc.274.25.17406 10364168
14. Koedel U Angele B Rupprecht T Wagner H Roggenkamp A Pfister HW Kirschning CJ Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis J Immunol 2003 170 1 438-444 12496429
15. Letiembre M Echchannaoui H Ferracin F Rivest S Landmann R Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis J Neuroimmunol 2005 16137770
16. Dziarski R Tapping RI Tobias PS Binding of bacterial peptidoglycan to CD14 J Biol Chem 1998 273 15 8680-8690 10.1074/jbc.273.15.8680 9535844
17. Ulmer AJ Salmalouti V Rietschel ET Flad HD Dziarsky R CD14, an innate immune receptor for various bacterial cell wall components Endotoxin in Health and DIsease New York, Dekker Brade H, Opal S, Vogel S, Morrison D 1999 1 463-471
18. Echchannaoui H Frei K Letiembre M Strieter RM Adachi Y Landmann R CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection J Leukoc Biol 2005 78 3 705-715 10.1189/jlb.0205063 15941778
19. Merlin T Woelky-Bruggmann R Fearns C Freudenberg M Landmann R Expression and role of CD14 in mice sensitized to lipopolysaccharide by Propionibacterium acnes Eur J Immunol 2002 32 3 761-772 10.1002/ 1521-4141(200203)32:3<761::AID-IMMU761>3.0.CO;2-5 11870620
20. Cauwels A Frei K Sansano S Fearns C Ulevitch R Zimmerli W Landmann R The origin and function of soluble CD14 in experimental bacterial meningitis J Immunol 1999 162 8 4762-4772 10202018
21. Manukyan M Triantafilou K Triantafilou M Mackie A Nilsen N Espevik T Wiesmuller KH Ulmer AJ Heine H Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1 Eur J Immunol 2005 35 3 911-921 10.1002/eji.200425336 15714590
22. Muroi M Ohnishi T Tanamoto K Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B J Biol Chem 2002 277 44 42372-42379 10.1074/jbc.M205966200 12196527
23. Muta T Takeshige K Essential roles of CD14 and lipopolysaccharide-binding protein for activation of toll-like receptor (TLR)2 as well as TLR4 Reconstitution of TLR2- and TLR4-activation by distinguishable ligands in LPS preparations Eur J Biochem 2001 268 16 4580-4589 10.1046/j.1432-1327.2001.02385.x 11502220
24. Gerber J Raivich G Wellmer A Noeske C Kunst T Werner A Bruck W Nau R A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease Acta Neuropathol (Berl) 2001 101 5 499-508 11484822
25. Miner JR Heegaard W Mapes A Biros M Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center J Emerg Med 2001 21 4 387-392 10.1016/ S0736-4679(01)00407-3 11728765
26. Meli DN Loeffler JM Baumann P Neumann U Buhl T Leppert D Leib SL In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex J Neuroimmunol 2004 151 1-2 6-11 10.1016/j.jneuroim.2004.01.026 15145598
27. Nau R Eiffert H Modulation of release of proinflammatory bacterial compounds by antibacterials: Potential impact on course of inflammation and outcome in sepsis and meningitis Clin Microbiol Rev 2002 15 1 95-110 118062 11781269 10.1128/CMR.15.1.95-110.2002
28. Orman KL English BK Effects of antibiotic class on the macrophage inflammatory response to Streptococcus pneumoniae J Infect Dis 2000 182 5 1561-1565 10.1086/315861 11023483
29. Moore LJ Pridmore AC Dower SK Read RC Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae J Infect Dis 2003 188 7 1040-1048 10.1086/378238 14513425
30. Echchannaoui H Bachmann P Letiembre M Espinosa M Landmann R Regulation of Streptococcus pneumoniae distribution by Toll-like receptor 2 in vivo Immunobiology 2005 210 229-236 10.1016/j.imbio.2005.05.017 16164030
31. Blander JM Medzhitov R Regulation of phagosome maturation by signals from toll-like receptors Science 2004 304 5673 1014-1018 10.1126/ science.1096158 15143282
32. Yates RM Russell DG Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4 Immunity 2005 23 4 409-417 10.1016/j.immuni.2005.09.007 16226506